Postoperative hydrocephalus management may cause delays in adjuvant treatment following paediatric posterior fossa tumour resection: a multicentre retrospective observational study.
Ependymoma
Medulloblastoma
Predictive model
Ventriculoperitoneal shunt
Journal
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
ISSN: 1433-0350
Titre abrégé: Childs Nerv Syst
Pays: Germany
ID NLM: 8503227
Informations de publication
Date de publication:
02 2022
02 2022
Historique:
received:
12
05
2021
accepted:
20
09
2021
pubmed:
7
10
2021
medline:
5
4
2022
entrez:
6
10
2021
Statut:
ppublish
Résumé
Hydrocephalus persists in 10-40% of children with posterior fossa tumours (PFT). A delay in commencement of adjuvant therapy (AT) can negatively influence survival. The objective of this study was to determine whether postoperative cerebrospinal fluid (CSF) diversion procedures caused potentially preventable delays in AT. A retrospective study of children diagnosed with PFT requiring AT from 2004 to 2018 from two large centres was conducted. Data on histology, timing of ventriculo-peritoneal shunt (VPS) insertion, and AT was collected. The modified Canadian Preoperative Prediction Rule for Hydrocephalus (mCPPRH) score was calculated. The primary outcome was delay in AT beyond 40 days post-resection. Progression-free and overall survival were assessed. Out of 196 primary PFT resections, 144 fitted the inclusion criteria. Mean age was 6.57 ± 4.62. Histology was medulloblastoma (104), ependymoma (27), and others (13). Forty patients had a VPS inserted; 17 of these experienced a delay in AT. A total of 104 patients were not shunted; 15 of these had delayed AT (p = 0.0007). Patients who had a VPS insertion had longer intervals from surgery to commencement of AT (34.5 vs 30.8, p = 0.05). There was no significant difference in mCPPRH score between those who had a VPS (4.03) and those who did not (3.61; p = 0.252). Multivariable linear regression modelling did not show a significant effect of VPS or mCPPRH on progression-free survival or OS. CSF diversion procedures may cause a preventable delay in the initiation of adjuvant therapy. Early post-operative VP shunt insertion, rather than a 'wait and see policy' should be considered in order to reduce this delay.
Identifiants
pubmed: 34611762
doi: 10.1007/s00381-021-05372-9
pii: 10.1007/s00381-021-05372-9
doi:
Types de publication
Journal Article
Multicenter Study
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
311-317Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Gopalakrishnan CV, Dhakoji A, Menon G, Nair S (2012) Factors predicting the need for cerebrospinal fluid diversion following posterior fossa tumor surgery in children. Pediatr Neurosurg 48(2):93–101
doi: 10.1159/000343009
Riva-Cambrin J, Detsky AS, Lamberti-Pasculli M, Sargent MA, Armstrong D, Moineddin R et al (2009) Predicting postresection hydrocephalus in pediatric patients with posterior fossa tumors. J Neurosurg Pediatr 3(5):378–385
doi: 10.3171/2009.1.PEDS08298
Sklar CA (2002) Childhood brain tumors. J Pediatr Endocrinol Metab 15(Suppl 2):669–673
pubmed: 12092679
Bognár L, Borgulya G, Benke P, Madarassy G (2003) Analysis of CSF shunting procedure requirement in children with posterior fossa tumors. Childs Nerv Syst 19(5–6):332–336
doi: 10.1007/s00381-003-0745-x
Culley DJ, Berger MS, Shaw D, Geyer R (1994) An analysis of factors determining the need for ventriculoperitoneal shunts after posterior fossa tumor surgery in children. Neurosurgery 34(3):402–7; discussion 7–8.
Lin CT, Riva-Cambrin JK (2015) Management of posterior fossa tumors and hydrocephalus in children: a review. Childs Nerv Syst 31(10):1781–1789
doi: 10.1007/s00381-015-2781-8
Kortmann RD, Kühl J, Timmermann B, Mittler U, Urban C, Budach V et al (2000) Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT ’91. Int J Radiat Oncol Biol Phys 46(2):269–279
doi: 10.1016/S0360-3016(99)00369-7
Zeltzer PM, Boyett JM, Finlay JL, Albright AL, Rorke LB, Milstein JM et al (1999) Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children’s Cancer Group 921 randomized phase III study. J Clin Oncol 17(3):832–845
doi: 10.1200/JCO.1999.17.3.832
Bailey CC, Gnekow A, Wellek S, Jones M, Round C, Brown J et al (1995) Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II. Med Pediatr Oncol 25(3):166–78.
Sainte-Rose C, Cinalli G, Roux FE, Maixner R, Chumas PD, Mansour M et al (2001) Management of hydrocephalus in pediatric patients with posterior fossa tumors: the role of endoscopic third ventriculostomy. J Neurosurg 95(5):791–797
doi: 10.3171/jns.2001.95.5.0791
Srinivasan HL, Foster MT, van Baarsen K, Hennigan D, Pettorini B, Mallucci C (2020) Does pre-resection endoscopic third ventriculostomy prevent the need for post-resection CSF diversion after pediatric posterior fossa tumor excision? A historical cohort study and review of the literature. J Neurosurg Pediatr 1–10.
Paulsen AH, Lundar T, Lindegaard KF (2015) Pediatric hydrocephalus: 40-year outcomes in 128 hydrocephalic patients treated with shunts during childhood. Assessment of surgical outcome, work participation, and health-related quality of life. J Neurosurg Pediatr 16(6):633–41.
Beuriat PA, Puget S, Cinalli G, Blauwblomme T, Beccaria K, Zerah M et al (2017) Hydrocephalus treatment in children: long-term outcome in 975 consecutive patients. J Neurosurg Pediatr 20(1):10–18
doi: 10.3171/2017.2.PEDS16491
Foreman P, McClugage S, Naftel R, Griessenauer CJ, Ditty BJ, Agee BS et al (2013) Validation and modification of a predictive model of postresection hydrocephalus in pediatric patients with posterior fossa tumors. J Neurosurg Pediatr 12(3):220–226
doi: 10.3171/2013.5.PEDS1371
Wickham H (2016) ggplot2: Elegant graphics for data analysis: Springer-Verlag New York.
Kassambara A (2020) rstatix: pipe-friendly framework for basic statistical tests.
Kassambara A (2019) ggpubr: ‘ggplot2’ Based Publication Ready Plots.
Merchant TE, Bendel AE, Sabin ND, Burger PC, Shaw DW, Chang E, Wu S, Zhou T, Eisenstat DD, Foreman NK, Fuller CE, Anderson ET, Hukin J, Lau CC, Pollack IF, Laningham FH, Lustig RH, Armstrong FD, Handler MH, Williams-Hughes C, Kessel S, Kocak M, Ellison DW, Ramaswamy V (2019) Conformal radiation therapy for pediatric ependymoma, chemotherapy for incompletely resected ependymoma, and observation for completely resected, Supratentorial Ependymoma J Clin Oncol 37:974–983.
Chin AL, Moding EJ, Donaldson SS, Gibbs IC, Soltys SG, Hiniker SM et al (2018) Survival impact of postoperative radiotherapy timing in pediatric and adolescent medulloblastoma. Neuro Oncol 20(8):1133–1141
doi: 10.1093/neuonc/noy001
Di Rocco F, Jucá CE, Zerah M, Sainte-Rose C (2013) Endoscopic third ventriculostomy and posterior fossa tumors. World Neurosurg 79, 2S:S18.e15-S18.e19.
Dewan MC, Lim J, Shannon CN, Wellons JC 3